Back to results
US 6,579,890 B1Granted
Matrix metalloprotease inhibitors
AssigneeSyntex (U.S.A.) Inc.
InventorsStephen Horne, Teng J. Liak
Life of this patent
Estimating the term…
Abstract
Compounds of formula (I) and their pharmaceutically acceptable salts inhibit matrix metalloproteases, such as stromelysin, gelatinase, matrilysin and collagenase, and are useful in the treatment of mammals having disease-states alleviated by the inhibition of such matrix metalloproteases.
Claims7
A compound of the formula:
- wherein:
- R1 is mercapto, carboxy, or a group of the formula:
- where R6 is optionally substituted aryl or heteroaryl;
- R2 is alkyl, optionally substituted phenyl, or a group of the formula:
- wherein:
- A is CH2, O, NH, S, CH2—CH2, or NH—CH2;
- R10 is H, alkyl, alkoxy, alkylamino or acylamide;
- and
- R11 is H or halo;
- R7 is 4-pyridyl and p is 0;
- R3 is alkyl, cycloalkyl, aralkyl, or heteroaralkyl, where the aralkyl and heteroaryl groups may be optionally substituted and where the alkyl is optionally substituted by cycloalkyl, hydroxy, mercapto, alkylthio, aralkoxy, amino, mono- and diallkylamino, guanidino, N,N-dialkylguanidino, carbamoyl, aryl or heteroaryl;
- X is a group of the formula —(CH2)m—Y—(CH2)n—, where:
- Y is O, S, or a single bond,
- m is an integer from 0 to 4,
- n is an integer from 0 to 4, and
- m+n is an integer from 0 to 4;
- p is an integer from 0 to 4, provided that R2—X is biphenylalkyl when p is not 0;
- or a pharmaceutically acceptable salt thereof.
15 more elements
Dependencies are inferred from the claim text.